Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
to make corrections and additions.
Showing 10 of 71 results.
Ng JH, Yang W, Dember LM. Performance Characteristics of Candidate Criteria for Hemodialysis Arteriovenous Fistula Maturation. Clin J Am Soc Nephrol. 2023 Oct 01; 18(10):1321-1332. PMID: 37553865; PMCID: PMC10578636; DOI: 10.2215/CJN.0000000000000248;
Salas M, Gossell-Williams M, Yalamanchili P, Dhingra S, Malikova MA, Aimer O, Junaid T. The Use of Biomarkers in Pharmacovigilance: A Systematic Review of the Literature. Biomark Insights. 2023; 18:11772719231164528. PMID: 37077840; PMCID: PMC10108426; DOI: 10.1177/11772719231164528;
Malikova M.A. . 35th Annual Europe Meeting, Drug Information Association (DIA EUROPE 2023), March 24th, 2023, Basel, Switzerland. Abstract ID:101264. Risk-Based Quality and Safety Management in Clinical Trials with Combination Products in Global Regulatory Environment. 2023.
Akpoviroro O, Castagne-Charlotin M, Joyce NP, Malikova MA. Assessment of the Relationship Between Protocol Adherence, Study Complexity and Personnel in Surgical Clinical Trials. Ther Innov Regul Sci. 2023 Jul; 57(4):619-628. PMID: 36930415
He Y, Shiu YT, Imrey PB, Radeva MK, Beck GJ, Gassman JJ, Northrup HM, Roy-Chaudhury P, Berceli SA, Cheung AK. Association of Shear Stress with Subsequent Lumen Remodeling in Hemodialysis Arteriovenous Fistulas. Clin J Am Soc Nephrol. 2023 Jan 01; 18(1):72-83. PMID: 36446600; PMCID: PMC10101625; DOI: 10.2215/CJN.04630422;
Malikova M.A., Cole A., Trifirò G.; Racagni G., Van Liew D., Webster P., Brahmbhatt T. Frontiers in Drug Safety and Regulation. Establishing patient safety monitoring in the benefit-risk paradigm for off-label and emergency use of medications for COVID-19: A pharmacovigilance perspective. EPub. https://doi.org/10.3389/fdsfr.2022.1038235. 2022; 1-6. View Publication
Malikova M.A. The Symposium on Advanced Wound Care (SAWC). October 13-16th, 2022, Las Vegas, Nevada, USA.Abstract Book. Building Quality by Design into Wound Care Trials with Combination Products. 2022; 83-84. View Publication
Malikova M., Webster P., Brahmbhatt T. 21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities” 20–23, September 2022 Verona, Italy. Establishing Patient Safety Monitoring in the Benefit-Risk Paradigm for Off-Label and Emergency Use of Medications for COVID-19: A Pharmacovigilance Perspective. Drug Safety. Drug Safety. 2022; (45):1199–1200. View Publication
Palin K., V. Kugener V., Salas M., Malikova M., Price J., Webster P., Cole A., Ely D., Habibi S., Joshi P. 21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities”. Am2P: A New Accredited Academic Training Program in Pharmacovigilance and Pharmacoepidemiology Designed for US, Canadian and Caribbean Healthcare Professionals. Drug Safety. 2022; (45):1275–1276. View Publication
Malikova M. and Kaliaev A. 21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities”. Risk-Based Quality and Safety Management in Clinical Trials with Combination Devices in Changing Global Regulatory Environment. Drug Safety. Drug Safety. 2022; (45):1267. View Publication
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.